The role of Fas ligand in immune privilege
- PMID: 11733771
- DOI: 10.1038/35103104
The role of Fas ligand in immune privilege
Abstract
Immune privilege is a property of some sites in the body, whereby immune responses are limited or prevented. One explanation that has been proposed for this phenomenon is engagement of the pro-apoptotic molecule Fas by its ligand (FasL), which leads to apoptosis, and consequently limits an inflammatory response. This idea has recently been challenged, and here we review the evidence for and against a role for FasL in immune privilege.
Similar articles
-
Immune privilege or inflammation? The paradoxical effects of Fas ligand.Arch Immunol Ther Exp (Warsz). 2000;48(2):73-9. Arch Immunol Ther Exp (Warsz). 2000. PMID: 10807046 Review.
-
A vision of cell death: Fas ligand and immune privilege 10 years later.Immunol Rev. 2006 Oct;213:228-38. doi: 10.1111/j.1600-065X.2006.00430.x. Immunol Rev. 2006. PMID: 16972907 Review.
-
Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.Med Hypotheses. 1999 Jul;53(1):50-62. doi: 10.1054/mehy.1997.0712. Med Hypotheses. 1999. PMID: 10499826
-
Immune privilege or inflammation? Insights into the Fas ligand enigma.Nat Med. 2001 Mar;7(3):271-4. doi: 10.1038/85395. Nat Med. 2001. PMID: 11231613
-
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.J Clin Invest. 1997 Feb 1;99(3):396-402. doi: 10.1172/JCI119173. J Clin Invest. 1997. PMID: 9022072 Free PMC article.
Cited by
-
Biological aspects of tissue-engineered cartilage.Histochem Cell Biol. 2018 Apr;149(4):375-381. doi: 10.1007/s00418-018-1652-2. Epub 2018 Mar 6. Histochem Cell Biol. 2018. PMID: 29511835 Review.
-
A straightforward method for measuring binding affinities of ligands to proteins of unknown concentration in biological tissues.Chem Sci. 2025 Apr 11;16(20):8673-8681. doi: 10.1039/d5sc02460a. eCollection 2025 May 21. Chem Sci. 2025. PMID: 40313517 Free PMC article.
-
Cytolytic CD4(+) T cells in viral immunity.Expert Rev Vaccines. 2010 Dec;9(12):1453-63. doi: 10.1586/erv.10.132. Expert Rev Vaccines. 2010. PMID: 21105780 Free PMC article. Review.
-
Necroptosis in heart disease: Molecular mechanisms and therapeutic implications.J Mol Cell Cardiol. 2022 Aug;169:74-83. doi: 10.1016/j.yjmcc.2022.05.006. Epub 2022 May 18. J Mol Cell Cardiol. 2022. PMID: 35597275 Free PMC article. Review.
-
Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy.Mol Clin Oncol. 2015 Jan;3(1):151-156. doi: 10.3892/mco.2014.431. Epub 2014 Sep 26. Mol Clin Oncol. 2015. PMID: 25469286 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous